Those determined to outshine the market strategically focus on the selection of individual stocks. Well-chosen stocks have the potential to substantially boost your wealth.
The price of Iovance Biotherapeutics Inc (NASDAQ: IOVA) closed at $3.13 in the last session, up 25.70% from day before closing price of $2.49. In other words, the price has increased by $25.70 from its previous closing price. On the day, 48.99 million shares were traded. IOVA stock price reached its highest trading level at $3.175 during the session, while it also had its lowest trading level at $2.66.
Ratios:
We take a closer look at IOVA’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 3.64 and its Current Ratio is at 4.18. In the meantime, Its Debt-to-Equity ratio is 0.07 whereas as Long-Term Debt/Eq ratio is at 0.06.
On May 16, 2025, UBS Downgraded its rating to Neutral which previously was Buy but kept the price unchanged to $2.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Jun 05 ’25 when Kirby Daniel Gordon bought 30,000 shares for $1.84 per share. The transaction valued at 55,200 led to the insider holds 30,000 shares of the business.
Puri Raj K. bought 5,600 shares of IOVA for $9,743 on May 23 ’25. The Chief Regulatory Officer now owns 206,852 shares after completing the transaction at $1.74 per share. On May 14 ’25, another insider, Vogt Frederick G, who serves as the Interim CEO & General Counsel of the company, bought 25,000 shares for $1.69 each. As a result, the insider paid 42,250 and bolstered with 374,646 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, IOVA now has a Market Capitalization of 1045213504 and an Enterprise Value of 525504608. For the stock, the TTM Price-to-Sale (P/S) ratio is 4.91 while its Price-to-Book (P/B) ratio in mrq is 1.36. Its current Enterprise Value per Revenue stands at 2.471 whereas that against EBITDA is -1.44.
Stock Price History:
The Beta on a monthly basis for IOVA is 0.86, which has changed by -0.6571741 over the last 52 weeks, in comparison to a change of 0.16260707 over the same period for the S&P500. Over the past 52 weeks, IOVA has reached a high of $12.51, while it has fallen to a 52-week low of $1.64. The 50-Day Moving Average of the stock is 61.39%, while the 200-Day Moving Average is calculated to be -41.95%.
Shares Statistics:
According to the various share statistics, IOVA traded on average about 14.90M shares per day over the past 3-months and 23181720 shares per day over the past 10 days. A total of 333.93M shares are outstanding, with a floating share count of 271.39M. Insiders hold about 18.73% of the company’s shares, while institutions hold 64.19% stake in the company. Shares short for IOVA as of 1751241600 were 96777448 with a Short Ratio of 6.49, compared to 1748563200 on 86361273. Therefore, it implies a Short% of Shares Outstanding of 96777448 and a Short% of Float of 31.740000000000002.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
